PDCD1 and Carcinoma, Lewis Lung: In addition, interception of RSPO/LGR4 signaling could overcome the drug resistance of Lewis lung carcinoma to treatment with a PD-1 inhibitor and enhance the response to PD-1 immunotherapy (183).